Journal of radiosurgery and SBRT最新文献

{"title":"Reduced radiation necrosis in radiosurgical treatment of small brain metastases with 22 Gy.","authors":"Shearwood McClelland Iii, Todd R Mereniuk, May F Elbanna, Christina C Huang, Tim Lautenschlaeger, James C Miller, Gordon A Watson, Ryan M Rhome","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 4","pages":"329-330"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492050/pdf/rsbrt-7-330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39503039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis.","authors":"Brett H Diamond,&nbsp;Vikram Jairam,&nbsp;Shaharyar Zuberi,&nbsp;Jessie Y Li,&nbsp;Timothy J Marquis,&nbsp;Charles E Rutter,&nbsp;Henry S Park","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Single-fraction stereotactic radiosurgery (SF-SRS) is typically used to provide local control of brain metastases. Recently, hypofractionated stereotactic radiotherapy (HF-SRT) has been utilized for large brain metastases. Data comparing these two modalities are limited for brain metastases ≤3 cm.</p><p><strong>Methods: </strong>Patients with brain metastases receiving linear accelerator-based SF-SRS or HF-SRT were identified at three institutions. Local progression-free survival (LPFS), intracranial progression-free survival (ICPFS), overall survival (OS), and radionecrosis-free survival (RNFS) were determined from time of treatment.</p><p><strong>Results: </strong>108 patients (76 intact, 32 resected) with 184 brain metastases (142 intact, 42 resected) were included. There were no significant differences between SF-SRS and HF-SRT for intact metastases in 1-year LPFS (62.8% vs. 58.5%, p=0.631), ICPFS (56.9% vs. 55.3%, p=0.300), and OS (71.6% vs. 70.6%, p=0.096), or for resected metastases in 1-year LPFS (67.3% vs. 57.8%, p=0.288), ICPFS (64.8% vs. 57%, p=0.291), and OS (64.8% vs. 66.1%, p=0.603). There were also no significant differences in 1-year RNFS between SF-SRS and HF-SRT (92% vs. 92%, p=0.325).</p><p><strong>Conclusions: </strong>There were no significant differences in LPFS, ICPFS, OS, and RNFS between SF-SRS and HF-SRT for brain metastases ≤3 cm suggesting SF-SRS may be preferred due to similar outcomes and reduced number of fractions.</p>","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"179-187"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055233/pdf/rsbrt-7-187.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38907771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: Outcomes and failure patterns.","authors":"Stephen J Shamp,&nbsp;Saad Sheikh,&nbsp;Tangel Chang,&nbsp;Nicholas Damico,&nbsp;Phillip Linden,&nbsp;Afshin Dowlati,&nbsp;Mitchell Machtay,&nbsp;Tithi Biswas","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose/objectives: </strong>Outcomes of T2N0 lung cancer patients treated with stereotactic radiotherapy are not well known.</p><p><strong>Methods and materials: </strong>We conducted a single institution retrospective review of patients with T2N0 NSCLC who were treated with SBRT. The local, regional, distant control rates were calculated from available clinical data. Survival outcomes were determined using the Kaplan Meier method.</p><p><strong>Results: </strong>Fifty-six patients met our selection criteria. The two-year local control rate was 84.2%. The two and 5-year disease-free survival (DFS) and OS were 31.9% and 15.3% and 39.9% and 12.1%, respectively. Centroid BED₁₀ > 150Gy was associated with improved DFS, (p = 0.014), and OS on univariable analysis (p=0.0132).</p><p><strong>Conclusions: </strong>SBRT provides good local control for T2N0 NSCLC, but systemic failure remains problematic.</p>","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 4","pages":"271-277"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492054/pdf/rsbrt-7-277.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39504556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Robustness of single-isocenter multiple-metastasis stereotactic radiosurgery end-to-end testing across institutions.","authors":"Daniel Saenz,&nbsp;Niko Papanikolaou,&nbsp;Emmanouil Zoros,&nbsp;Evangelos Pappas,&nbsp;Michael Reiner,&nbsp;Lip Teck Chew,&nbsp;Hooi Yin Lim,&nbsp;Sam Hancock,&nbsp;Alex Nebelsky,&nbsp;Christopher Njeh,&nbsp;Georgios Anagnostopoulos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The accuracy of stereotactic radiosurgery (SRS) to multiple metastases with a single-isocenter using high definition dynamic radiosurgery (HDRS) was evaluated across institutions. An SRS plan was delivered at six HDRS-capable institutions to an anthropomorphic phantom consisting of point, film, and 3D-gel dosimeters. Direct dose comparison and gamma analysis were used to evaluate the accuracy. Point measurements averaged across institutions were within 1.2±0.5%. The average gamma passing rate in the film was 96.6±2.2% (3%/2 mm). For targets within 4 cm of the isocenter, the 3D dosimetric gel gamma passing rate averaged across institutions was >90% (3%/2 mm). The targeting accuracy of high definition dynamic radiosurgery assessed by geometrical offset of the center of dose distributions across multiple institutions in this study was within 1 mm for targets within 4 cm of isocenter. Across variations in clinical practice, comparable dosimetry and localization is possible with this treatment planning and delivery technique.</p>","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"223-232"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055241/pdf/rsbrt-7-232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dosimetric comparison of Gamma Knife® Icon^TM and linear accelerator-based fractionated stereotactic radiotherapy (FSRT) plans for the re-irradiation of large (>14 cm³) recurrent glioblastomas.","authors":"Matthew E Schelin,&nbsp;Haisong Liu,&nbsp;Ayesha Ali,&nbsp;Wenyin Shi,&nbsp;Yan Yu,&nbsp;Karen E Mooney","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Our objective is to investigate dosimetric differences between clinically deliverable Gamma Knife^® (GK) Icon™ and linac-based FSRT plans on the basis of normal brain dose sparing for large (>14 cm³) recurrent glioblastomas (GBM). Sixteen patients with large, recurrent GBM were treated using re-irradiation via linac-based FSRT, 35 Gy in 10 fractions. For each patient, a new GK FSRT plan was created in Leksell GammaPlan^® V11 (LGP). To maintain clinical deliverability, the LGP optimization included a planning goal of treatment time <20 minutes per fraction. Dosimetric comparison of coverage and normal brain dose between the linac and GK treatment plans was performed in MIM. The GK FSRT plans had significantly (p < 0.05) lower mean normal brain dose values (-8.85%), mean values of normal brain V20 (-32.4%) and V12 (-25.9%), and a lower mean V4 (-10.0%). GK FSRT plans have the potential to reduce the risk of radiation-related toxicities.</p>","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"233-243"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055238/pdf/rsbrt-7-243.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Workflow guide to delivering a safe breast treatment using a novel stereotactic radiation delivery system.","authors":"Elizabeth M Nichols,&nbsp;Mariana Guerrero,&nbsp;Sarah McAvoy,&nbsp;Terri Biggins,&nbsp;ByongYong Yi,&nbsp;Stewart J Becker","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"249-252"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055237/pdf/rsbrt-7-252.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unusual presentation of an extrahepatic migration of a fiducial implanted for stereotactic body radiotherapy.","authors":"Meenu Jose,&nbsp;George Shibu Pottikyal,&nbsp;Ajay Sasidharan,&nbsp;Sruthi K Reddy,&nbsp;Annex Edappattu Haridas,&nbsp;Debnarayan Dutta","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"257-260"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055242/pdf/rsbrt-7-260.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SBRT to chest wall metastasis from hemangiopericytoma: A case report.","authors":"Anjali V Ramdulari,&nbsp;Haresh Kunhiparambath,&nbsp;Subhash Gupta,&nbsp;Astha Srivastava,&nbsp;Seema Sharma,&nbsp;Kavneet Kaur,&nbsp;Vaishali Suri","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"261-262"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055235/pdf/rsbrt-7-262.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience.","authors":"Timothy D Smile,&nbsp;Chandana A Reddy,&nbsp;George Qiao-Guan,&nbsp;W Ian Winter,&nbsp;Kevin L Stephans,&nbsp;Neil M Woody,&nbsp;Ehsan H Balagamwala,&nbsp;Sudha R Amarnath,&nbsp;Anthony Magnelli,&nbsp;Mariam M AlHilli,&nbsp;Chad M Michener,&nbsp;Haider Mahdi,&nbsp;Robert L DeBernardo,&nbsp;Peter G Rose,&nbsp;Sheen S Cherian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose/objectives: </strong>Metastasis-directed therapy with stereotactic body radiotherapy (SBRT) in the setting of oligometastatic disease is a rapidly evolving paradigm given ongoing improvements in systemic therapies and diagnostic modalities. However, SBRT to targets in the abdomen and pelvis is historically associated with concerns about toxicity. The purpose of this study was to evaluate the safety and efficacy of SBRT to the abdomen and pelvis for women with oligometastases from primary gynecological tumors.</p><p><strong>Materials/methods: </strong>From our IRB-approved registry, all patients who were treated with SBRT between 2014 and 2020 were identified. Oligometastatic disease was defined as 1 to 5 discrete foci of clinical metastasis radiographically diagnosed by positron emission tomography (PET) and/or computerized tomography (CT) imaging. The primary endpoint was local control at 12 months. Local and distant control rates were estimated using the Kaplan-Meier method. Time intervals for development of local progression and distant progression were calculated based on follow up visits with re-staging imaging. Acute and late toxicity outcomes were determined based on Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.</p><p><strong>Results: </strong>We identified 34 women with 43 treated lesions. Median age was 68 years (range 32-82), and median follow up time was 12 months (range 0.2-54.0). Most common primary tumor sites were ovarian (n=12), uterine (n=11), and cervical (n=7). Median number of previous lines of systemic therapy agents at time of SBRT was 2 (range 0-10). Overall, SBRT was delivered to 1 focus of oligometastasis in 29 cases, 2 foci in 2 cases, 3 foci in 2 cases, and 4 foci in 1 case. All patients were treated comprehensively with SBRT to all sites of oligometastasis. Median prescription dose was 24 Gy (range 18-54 Gy) in 3 fractions (range 3-6) to a median prescription isodose line of 83.5% (range 52-95). Local control by lesion at 12 and 24 months was 92.5% for both time points. Local failure was observed in three treated sites among two patients, two of which were at 11 months in one patient, and the other at 30 months. Systemic control rate was 60.2% at 12 months. Overall survival at 12 and 24 months was 85% and 70.2%, respectively. Acute grade 2 toxicities included nausea (n=3), and there were no grade > 3 acute toxicities. Late grade 1 toxicities included diarrhea (n=1) and fatigue (n=1), and there were no grade > 2 toxicities.</p><p><strong>Conclusion: </strong>SBRT to oligometastatic gynecologic malignancies in the abdomen and pelvis is feasible with encouraging preliminary safety and local control outcomes. This approach is associated with excellent local control and low rates of toxicity during our follow-up interval. Further investigations into technique, dose-escalation and utilization are warranted.</p>","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"189-197"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055243/pdf/rsbrt-7-197.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38907772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seeing is believing: A roadmap for implementing bolus-tracked multiphasic CT simulation for ablative radiotherapy of abdominal malignancies.","authors":"Devon J Godfrey,&nbsp;Sarah Jo Stephens,&nbsp;Daniele Marin,&nbsp;Michael J Moravan,&nbsp;Joseph K Salama,&nbsp;Manisha Palta","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"253-255"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055236/pdf/rsbrt-7-255.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38828287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}